publication venue for
- A Differential Equation Based Modelling Approach to Predict Supersaturation and In Vivo Absorption from In Vitro Dissolution-Absorption System (idas2) Data. 1-12. 2021
- In vitro model for predicting the access and distribution of drugs in the brain using hCMEC/D3 cells.. 120-126. 2021
- Sphingolipid extracts enhances gene delivery of cationic lipid vesicles into retina and brain. 103-112. 2021
- Effect of thickener on disintegration, dissolution and permeability of common drug products for elderly patients. 168-176. 2020
- In vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditions. 229-237. 2020
- Two-step in vitro-in vivo correlations: Deconvolution and convolution methods, which one gives the best predictability? Comparison with one-step approach. 185-197. 2020
- Covalently crosslinked organophosphorous derivatives-chitosan hydrogel as a drug delivery system for oral administration of camptothecin. 174-183. 2019
- Mechanisticanalysisandexperimentalverificationofbicarbonatecontrolledentericcoatdissolution:Potentialinvivoimplications. 47-58. 2019
- Stability of the packaging system and storage conditions of human mesenchymal ítem cell for intraarterial clinical application in patient with critical limb ischaemia. 459-468. 2019
- Gastric Emptying and Intestinal Appearance of Nonabsorbable Drugs Phenol Red and Paromomycin in Human Subjects: A Multi-Compartment Stomach Approach. 162-174. 2018
- Preclinical models for colonic absorption, application to controlled release formulation development.. 247-259. 2018
- Low molecular weight oligochitosans for non-viral retinal gene therapy. 131-140. 2013
- Low molecular weight oligochitosans for non-viral retinal gene therapy.. 315-327. 2012
- A topological-substructural molecular design (TOPS-MODE) approach to determining pharmacokinetics and pharmacological properties of 6-fluoroquinolones derivatives. 197-206. 2003
- Transintestinal secretion of ciprofloxacin, grapafloxacin and sparfloxacin. 241-246. 2003
- Transintestinal secretion of ciprofloxacin, grepafloxacin and sparfloxacin: in vitro and in situ inhibition studies. 241-246. 2003
- The influence of active secretion processes on intestinal absorption of salbutamol in the rat. 31-37. 2001